Multiply Labs, a San Francisco, CA-based robotics company developing automated manufacturing systems for the production of individualized drugs, raised $20m in Series A financing.
The round, which brought total funding raised to date to more than $25m, was led by Casdin Capital with participation from new investors Lux Capital and Pathfinder, Founders Fund’s early stage investment vehicle, Fifty Years and Garage Capital. In conjunction with the funding, Michael Doherty, a representative of Casdin Capital, will join Multiply Labs’ Board of Directors.
The company intends to use the funds to grow its installed robotic production capacity, and to apply its tech to new life-saving therapies.
Led by Fred Parietti, PhD, Co-founder and CEO, Multiply Labs is developing cloud-controlled robotic systems for the production of experimental cell therapies in collaboration with a Consortium of industrial and research organizations in the space.